AAAAAA

   
Results: 1-11 |
Results: 11
Determination of linezolid in human serum and urine by high-performance liquid chromatography
Authors: Borner, K Borner, E Lode, H
Citation: K. Borner et al., Determination of linezolid in human serum and urine by high-performance liquid chromatography, INT J ANT A, 18(3), 2001, pp. 253-258
Efficient case-based structure generation for design support
Authors: Borner, K
Citation: K. Borner, Efficient case-based structure generation for design support, ARTIF INT R, 16(2), 2001, pp. 87-118
Atovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosis
Authors: Scholer, N Krause, K Kayser, O Muller, RH Borner, K Hahn, H Liesenfeld, O
Citation: N. Scholer et al., Atovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosis, ANTIM AG CH, 45(6), 2001, pp. 1771-1779
Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection
Authors: Peters, K Leitzke, S Diederichs, JE Borner, K Hahn, H Muller, RH Ehlers, S
Citation: K. Peters et al., Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection, J ANTIMICRO, 45(1), 2000, pp. 77-83
Metabolism of ifosfamide to chloroacetaldehyde contributes to antitumor activity in vivo
Authors: Borner, K Kisro, J Bruggemann, SK Hagenah, W Peters, SO Wagner, T
Citation: K. Borner et al., Metabolism of ifosfamide to chloroacetaldehyde contributes to antitumor activity in vivo, DRUG META D, 28(5), 2000, pp. 573-576
Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin, and moxifloxacin after single oral administration in healthy volunteers
Authors: Lubasch, A Keller, I Borner, K Koeppe, P Lode, H
Citation: A. Lubasch et al., Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin, and moxifloxacin after single oral administration in healthy volunteers, ANTIM AG CH, 44(10), 2000, pp. 2600-2603
Unorthodox temperature conditions: Opinions and supplementary observationsfrom bioanalytical forum participants
Authors: Brinkman, UAT Hill, HM Borner, K Reid, E
Citation: Uat. Brinkman et al., Unorthodox temperature conditions: Opinions and supplementary observationsfrom bioanalytical forum participants, CHROMATOGR, 52, 2000, pp. S57-S59
Determination of gatifloxacin in human serum and urine by HPLC
Authors: Borner, K Hartwig, H Lode, H
Citation: K. Borner et al., Determination of gatifloxacin in human serum and urine by HPLC, CHROMATOGR, 52, 2000, pp. S105-S107
Annotations by supplement editor and forum participants' remarks
Authors: Jonsson, JA Wilson, ID Zimmer, D Mallett, D Muirhead, D Stobaugh, JF Nilsson, S Perrett, D Blaschke, G Houghton, E Hill, HM van der Stel, DJK Matuszewski, BK Long, JM Montanari, D Brinkman, UAT Laugher, L Munn, AD Saunders, KC Borner, K James, ID Overton, P
Citation: Ja. Jonsson et al., Annotations by supplement editor and forum participants' remarks, CHROMATOGR, 52, 2000, pp. S120-S125
Determination of trovafloxacin in human body fluids by high-performance liquid chromatography
Authors: Borner, K Hartwig, H Lode, H
Citation: K. Borner et al., Determination of trovafloxacin in human body fluids by high-performance liquid chromatography, J CHROMAT A, 846(1-2), 1999, pp. 175-180
HPLC determination of clofazimine in tissues and serum of mice after intravenous administration of nanocrystalline or liposomal formulations
Authors: Borner, K Hartwig, H Leitzke, S Hahn, H Muller, RH Ehlers, S
Citation: K. Borner et al., HPLC determination of clofazimine in tissues and serum of mice after intravenous administration of nanocrystalline or liposomal formulations, INT J ANT A, 11(1), 1999, pp. 75-79
Risultati: 1-11 |